Linda Lebon
Algemeen Adviseur bij OSE IMMUNOTHERAPEUTICS
Actieve functies van Linda Lebon
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
OSE IMMUNOTHERAPEUTICS | Algemeen Adviseur | 20-12-2021 | - |
Loopbaan van Linda Lebon
Eerdere bekende functies van Linda Lebon
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
BIOSENIC SA | Algemeen Adviseur | 29-10-2018 | 01-09-2021 |
ARGENX SE | Algemeen Adviseur | - | - |
iTeos Therapeutics SA
iTeos Therapeutics SA Pharmaceuticals: MajorHealth Technology iTeos Therapeutics SA engages in the discovery of immunomodulators for cancer therapy. It operates as a biotechnology company which focuses on targeting metabolism of the tumor microenvironment through development of small-molecule immunomodulators for cancer treatment. The firm develops small molecules designed to target the tumor microenvironment by inhibiting cancer-induced immune suppression. Targeting such resistance mechanisms will enhance the clinical efficacy of both standards of care treatments as well as the newer immunomodulatory therapies based on the blockade of immune checkpoints. The company was founded in 2011 by Michel Detheux and Benoit Van den Eynde and is headquartered in Gosselies, Belgium. | Algemeen Adviseur | - | - |
Opleiding van Linda Lebon
École des Hautes Études Commerciales de Paris | Masters Business Admin |
Centre Hospitalier Universitaire de Liege | Graduate Degree |
Statistieken
Internationaal
België | 4 |
Frankrijk | 3 |
Nederland | 2 |
Operationeel
General Counsel | 4 |
Masters Business Admin | 1 |
Graduate Degree | 1 |
Sectoraal
Health Technology | 5 |
Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
ARGENX SE | Health Technology |
OSE IMMUNOTHERAPEUTICS | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
iTeos Therapeutics SA
iTeos Therapeutics SA Pharmaceuticals: MajorHealth Technology iTeos Therapeutics SA engages in the discovery of immunomodulators for cancer therapy. It operates as a biotechnology company which focuses on targeting metabolism of the tumor microenvironment through development of small-molecule immunomodulators for cancer treatment. The firm develops small molecules designed to target the tumor microenvironment by inhibiting cancer-induced immune suppression. Targeting such resistance mechanisms will enhance the clinical efficacy of both standards of care treatments as well as the newer immunomodulatory therapies based on the blockade of immune checkpoints. The company was founded in 2011 by Michel Detheux and Benoit Van den Eynde and is headquartered in Gosselies, Belgium. | Health Technology |
Bone Therapeutics SA
Bone Therapeutics SA Pharmaceuticals: MajorHealth Technology Bone Therapeutics SA is a cell therapy company, which engages in the regenerative therapy addressing for unmet medical needs in the field of bone diseases and orthopedics. Its products include Allob and JTA-004. The company was founded by Jacques Reymann on June 16, 2006 and is headquartered in Gosselies, Belgium. | Health Technology |
- Beurs
- Insiders
- Linda Lebon
- Ervaring